Trade GRFS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Grifols, S.A. American Depositary Shares (GRFS) is trading at US$7.69, down 1.66% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$5.44B. Over the past 52 weeks, GRFS has traded between US$6.96 and US$10.23. On Syfe you can trade GRFS with $0 commission and add it to your watchlist.
| Previous close | US$7.82 |
|---|---|
| Market cap | US$5.44B |
| P/E ratio | 6.77 |
| 52-week range | US$6.96 – US$10.23 |
| Dividend yield | 1.11% |
| Volume | 322.32K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Grifols, S.A. American Depositary Shares
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.
Year: 2011
Grifols Begins Dosing Patients in Two Separate Phase 3 Trials
Jul 16, 12:51 PM · MT Newswires
Grifols Launches Fesilty Blood Clotting Concentrate in US
Jun 15, 12:33 PM · MT Newswires
Sector Update: Healthcare Stocks Steady Pre-Bell Friday
May 8, 1:16 PM · MT Newswires
Sector Update: Health Care
May 8, 12:56 PM · MT Newswires
Stay on top of GRFS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
